RedCarpetLife
2268
In the world today
Vikram Punia

Vikram Punia

V. Punia
-18.26% | - $-389.35M
$1.74 B ₹ 15,855 Cr
Real Time Net Worth #2268 Ranking as of 21 Feb 2026 By Forbes

More on Vikram Punia

Gender

Male

Age

59Y

Country

Russia

Born On

January, 1967

Deceased

No

Relationship Status

Unknown

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

Pharmasyntez

Titles

Founder & Chairman

Sources of Wealth

Pharmasyntez

Industry

Pharmaceuticals, Healthcare

About Vikram Punia


V ikram Punia is an Indian-born Russian billionaire who is the founder and chairman of the pharmaceutical company, Pharmasyntez. He moved to Russia in the early 1990s to study and has since built one of the country's largest and most successful domestic drugmakers. The company has a strong focus on producing drugs for the treatment of socially significant diseases, such as tuberculosis, HIV, and cancer, and is a major supplier to the Russian government's healthcare system.

The company's growth has been fueled by the Russian government's focus on import substitution and on developing a strong domestic pharmaceutical industry. He has become a major figure in the Russian healthcare sector and has been rewarded for his contributions with Russian citizenship. His wealth is derived from his ownership of the privately held pharmaceutical enterprise he founded.

Advertisement

Quick Reads


  • Founder and Chairman of the Russian drugmaker Pharmasyntez.
  • Born in India, he is now a Russian citizen.
  • His company is a major producer of drugs for diseases like TB, HIV, and cancer.
  • A major supplier to the Russian government's healthcare system.
  • His success is tied to Russia's import substitution policies.

Early Life and Background


Vikram Punia is a Russian businessman, the self-made billionaire Founder and Executive of Pharmasyntez PJSC, a major Russian manufacturer of generic and proprietary pharmaceutical products. His career is rooted in pharmaceuticals, R&D, and entrepreneurial audacity.

Punia holds an M.D. (Doctor of Medicine) degree (from a related source). His philosophical approach centers on scale, import substitution, and long-term commitment to affordable domestic drug production (pioneering the modern Russian generic drug model). He founded Pharmasyntez in 1997, recognizing the immense, untapped domestic demand for affordable, locally produced essential drugs.

  • Pharmasyntez (Founder & Executive): The core private asset, a major Russian manufacturer of generic and proprietary drugs (specializing in anti-tuberculosis, HIV/AIDS, and oncology treatments).
  • Pharmaceutical Focus: His success is built on scale manufacturing and dominating the domestic market for affordable generics (a key structural role in the Russian healthcare supply chain).
  • Academic Background: He holds an M.D. degree (from a related source).
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and R&D and leveraging the massive Russian government focus on import substitution.

Career Journey of Vikram Punia


Vikram Punia's strategic genius was his commitment to local production. He founded Pharmasyntez in 1997, successfully building it into a national force by specializing in high-volume manufacturing of essential generic drugs, particularly for infectious diseases. His structural contribution is immense: pioneering the scale manufacturing and professionalization of the Russian generic drug sector, significantly reducing the country's reliance on imported medicines.

His wealth is secured by the colossal, long-term, stable profitability of the Russian pharmaceutical and healthcare sector.

Advertisement

Vikram Punia's Timeline


1997:

Founds Pharmasyntez PJSC (Founding).

2000s:

Pharmasyntez expands aggressively into scale generic manufacturing (Industrial Apex).

Ongoing:

Continues as Founder and Executive, guiding the massive pharmaceutical giant (Executive Oversight).

Major Business Ventures and Investments


Vikram Punia's wealth is concentrated in his founding equity and continued executive leadership of the private pharmaceutical giant, Pharmasyntez PJSC, and his private investments.

  • Pharmasyntez (Founder & Executive): The core private asset, a major Russian manufacturer of generic and proprietary drugs (specializing in anti-tuberculosis, HIV/AIDS, and oncology treatments).
  • Pharmaceutical Focus: His success is built on scale manufacturing and dominating the domestic market for affordable generics.
  • Academic Background: He holds an M.D. degree (from a related source).
  • Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and R&D and leveraging the massive Russian government focus on import substitution.

Advertisement

Philanthropy and Social Impact


Vikram Punia's social impact stems from Pharmasyntez's role in providing essential, affordable generic medicines, significantly contributing to public health and medical access in Russia. The company's focus on essential drug production for infectious diseases addresses critical health needs. His personal philanthropy supports various community and educational initiatives.

His personal philanthropy supports various community and educational initiatives.

Fashion, Style, and Lifestyle


Vikram Punia maintains the professional, composed style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic reflects serious authority and stability, typical of a leader in the specialized pharmaceutical sector.

Residing in Irkutsk, Russia, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, quality control, and the long-term, stable growth of the healthcare supply chain.

Advertisement

Quotes and Philosophy


“The core mission of our company is to guarantee that essential medicines are accessible and affordable for the people of our country.”

Fun Facts & Trivia


  • He is the Founder and Executive of Pharmasyntez, a major Russian generic drug manufacturer.
  • Pharmasyntez is a key supplier of drugs for anti-tuberculosis and HIV/AIDS treatment in Russia.
  • He holds an M.D. (Doctor of Medicine) degree.
  • His fortune is tied to the successful monetization and scale of the Russian generic drug sector.
  • His philosophy emphasizes import substitution and technological independence.

Advertisement

More Profiles


Ben Silbermann

+4.2% | +$47.00M

Eduardo Vivas

+1.51% | +$49.17M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content